Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 1990Journal of Cardiovascular Pharmacology

Hypertension, dyslipidemia, and glucose intolerance act synergistically to increase coronary artery disease risk through mechanisms involving endothelial dysfunction and vascular cell proliferation.

View Full Paper
Ask AI
Bookmark
Share

Design

Review

Key result

Hypertension, dyslipidemia, and glucose intolerance act synergistically to increase coronary artery disease risk through mechanisms involving endothelial dysfunction and vascular cell proliferation.

Authors

VDVictor J. Dzau

Discussion

Loading...

Member takes

Overview

Hypothesis-generating for shared neurohormonal and genetic bases in cardiometabolic clustering; leaves open confirmation before any practice implications.

PICO

P
Population
Atherosclerosis and Hypertension

Highlights the synergistic pathophysiological mechanisms by which hypertension, dyslipidemia, and glucose intolerance contribute to atherosclerosis, emphasizing the need for comprehensive risk factor management.

Cite This Study

Victor J. Dzau (1990) conducted a review in Atherosclerosis and Hypertension. Hypertension, dyslipidemia, and glucose intolerance act synergistically to increase coronary artery disease risk through mechanisms involving endothelial dysfunction and vascular cell proliferation.

synapsesocial.com/papers/6a6409a876d7fa26081be129https://doi.org/10.1097/00005344-199000005-00009
View Full Paper
Ask AI
Bookmark
Share